Per this background and based only on the observed changes of ERCC2 and XRCC1 mRNA expression, we may hypothesize that miR-92a-3p improves platinum sensitivity in colon cancer cell lines by downregulation of ERCC2 and XRCC1 expression. The gene discussed is XRCC1; the disease is malignant colon neoplasm.